<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Neuropsychopharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Int. J. Neuropsychopharmacol</journal-id>
<journal-id journal-id-type="publisher-id">ijnp</journal-id>
<journal-title-group>
<journal-title>International Journal of Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1461-1457</issn>
<issn pub-type="epub">1469-5111</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
<publisher-loc>US</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32124922</article-id>
<article-id pub-id-type="pmc">7177167</article-id>
<article-id pub-id-type="doi">10.1093/ijnp/pyaa014</article-id>
<article-id pub-id-type="publisher-id">pyaa014</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Regular Research Article</subject>
</subj-group>
<subj-group subj-group-type="category-taxonomy-collection">
<subject>AcademicSubjects/MED00415</subject>
<subject>AcademicSubjects/SCI01870</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Upregulation of TRPC6 Mediated by <italic>PAX6</italic> Hypomethylation Is Involved in the Mechanical Allodynia Induced by Chemotherapeutics in Dorsal Root Ganglion</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xiang-Zhong</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="author-notes" rid="fn-0001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>De-Xing</given-names>
</name>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="author-notes" rid="fn-0001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bai</surname>
<given-names>Xiao-Hui</given-names>
</name>
<xref ref-type="aff" rid="AF0003">3</xref>
<xref ref-type="author-notes" rid="fn-0001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ding</surname>
<given-names>Huan-Huan</given-names>
</name>
<xref ref-type="aff" rid="AF0004">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Meng</given-names>
</name>
<xref ref-type="aff" rid="AF0004">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deng</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="AF0005">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mai</surname>
<given-names>Jing-Wen</given-names>
</name>
<xref ref-type="aff" rid="AF0002">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Yan-Ling</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Su-Bo</given-names>
</name>
<xref ref-type="aff" rid="AF0006">6</xref>
<xref ref-type="author-notes" rid="fn-0002"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ruan</surname>
<given-names>Xiang-Cai</given-names>
</name>
<xref ref-type="aff" rid="AF0005">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xue-Qin</given-names>
</name>
<xref ref-type="aff" rid="AF0007">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xin</surname>
<given-names>Wen-Jun</given-names>
</name>
<xref ref-type="aff" rid="AF0004">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Ting</given-names>
</name>
<xref ref-type="aff" rid="AF0004">4</xref>
<xref ref-type="author-notes" rid="fn-0002"></xref>
<xref ref-type="corresp" rid="c1"></xref>
<!--<email>xuting8@mail.sysu.edu.cn</email>-->
</contrib>
</contrib-group>
<aff id="AF0001"><label>1</label>
<institution>The Third Affiliated Hospital, Sun Yet-Sen University,</institution> Guangzhou, Guangdong, <country country="CN">China</country></aff>
<aff id="AF0002"><label>2</label>
<institution>Department of Anesthesiology, Huizhou Central People’s Hospital</institution>, Huizhou, Guangdong, <country country="CN">China</country></aff>
<aff id="AF0003"><label>3</label>
<institution>Department of Anesthesiology, Sun Yat-sen Memorial Hospital</institution> Guangzhou, <country country="CN">China</country></aff>
<aff id="AF0004"><label>4</label>
<institution>Zhongshan School of Medicine, Guangdong Province Key Laboratory of Brain Function and Disease Sun Yat-Sen University</institution>, Guangzhou, <country country="CN">China</country></aff>
<aff id="AF0005"><label>5</label>
<institution>Department of Anesthesia and Pain Medicine, Guangzhou First People’s Hospital, Guangzhou Medical University</institution>, Guangzhou, <country country="CN">China</country></aff>
<aff id="AF0006"><label>6</label>
<institution>Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Rehabilitation Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University</institution>, Guangzhou, Guangdong, <country country="CN">China</country></aff>
<aff id="AF0007"><label>7</label>
<institution>The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital),</institution> Guangzhou, <country country="CN">China</country></aff>
<author-notes>
<corresp id="c1">Correspondence: Ting Xu, PhD, Department of Physiology and Pain Research Center, Guangdong Province Key Laboratory of Brain Function and Disease, Sun Yat-Sen University, 74 Zhongshan Rd. 2, Guangzhou, China (<email>xuting8@mail.sysu.edu.cn</email>).</corresp>
<fn id="fn-0001">
<p>X.-Z.Z., D.-X.L., and X.-H.B. contributed equally to this work.</p>
</fn>
<fn id="fn-0002">
<p>T.X., and S.-B.Z. designed this project and wrote the article together.</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date iso-8601-date="2020-03-02" pub-type="epub">
<day>02</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>02</day>
<month>3</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>23</volume>
<issue>4</issue>
<fpage>257</fpage>
<lpage>267</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>01</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="corrected-typeset">
<day>02</day>
<month>4</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020. Published by Oxford University Press on behalf of CINP.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
</license>
</permissions>
<self-uri xlink:href="pyaa014.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<sec id="s0100">
<title>Background</title>
<p>Although the action mechanism of antineoplastic agents is different, oxaliplatin, paclitaxel, or bortezomib as first-line antineoplastic drugs can induce painful neuropathy. In rodents, mechanical allodynia is a common phenotype of painful neuropathy for 3 chemotherapeutics. However, whether there is a common molecular involved in the different chemotherapeutics-induced painful peripheral neuropathy remains unclear.</p>
</sec>
<sec id="s0101">
<title>Methods</title>
<p>Mechanical allodynia was tested by von Frey hairs following i.p. injection of vehicle, oxaliplatin, paclitaxel, or bortezomib in Sprague-Dawley rats. Reduced representation bisulfite sequencing and methylated DNA immunoprecipitation were used to detect the change of DNA methylation. Western blot, quantitative polymerase chain reaction, chromatin immunoprecipitation, and immunohistochemistry were employed to explore the molecular mechanisms.</p>
</sec>
<sec id="s0102">
<title>Results</title>
<p>In 3 chemotherapeutic models, oxaliplatin, paclitaxel, or bortezomib accordantly upregulated the expression of transient receptor potential cation channel, subfamily C6 (TRPC6) mRNA and protein without affecting the DNA methylation level of TRPC6 gene in DRG. Inhibition of TRPC6 by using TRPC6 siRNA (i.t., 10 consecutive days) relieved mechanical allodynia significantly following application of chemotherapeutics. Furthermore, the downregulated recruitment of DNA methyltransferase 3 beta (DNMT3b) at paired box protein 6 (PAX6) gene led to the hypomethylation of PAX6 gene and increased PAX6 expression. Finally, the increased PAX6 via binding to the TPRC6 promoter contributes to the TRPC6 increase and mechanical allodynia following chemotherapeutics treatment.</p>
</sec>
<sec id="s0103">
<title>Conclusions</title>
<p>The TRPC6 upregulation through DNMT3b-mediated PAX6 gene hypomethylation participated in mechanical allodynia following application of different chemotherapeutic drugs.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Chemotherapeutics</kwd>
<kwd>TRPC6</kwd>
<kwd>PAX6</kwd>
<kwd>mechanical allodynia</kwd>
<kwd>DNA methylation</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>National Natural Science Foundation of China</institution>
<institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
</institution-wrap>
</funding-source>
<award-id>81801103</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>China Postdoctoral Science Foundation</institution>
<institution-id institution-id-type="DOI">10.13039/501100002858</institution-id>
</institution-wrap>
</funding-source>
<award-id>2018M631019</award-id>
<award-id>2019T120767</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Fundamental Research Funds for the Central Universities</institution>
<institution-id institution-id-type="DOI">10.13039/501100012226</institution-id>
</institution-wrap>
</funding-source>
<award-id>18ykpy41</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Guangzhou Innovation Platform construction Project</institution>
</institution-wrap>
</funding-source>
<award-id>2060404</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Natural Science Foundation of Guangdong Province</institution>
<institution-id institution-id-type="DOI">10.13039/501100003453</institution-id>
</institution-wrap>
</funding-source>
<award-id>2019A1515010871</award-id>
<award-id>B13037</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="11"></page-count>
</counts>
</article-meta>
</front>
<body>
<boxed-text orientation="portrait" position="float">
<caption>
<title>Significance Statement</title>
</caption>
<p>Activation of PAX6/TRPC6 in DRG neurons may be a common signal pathway for mechanical allodynia following oxaliplatin, paclitaxel, or bortezomib application. A DNA hypomethylation-mediated epigenetic mechanism in the <italic>PAX6</italic> gene contributed to the upregulation of the PAX6/TRPC6 pathway. Targeted on PAX6/TRPC6, signaling may provide a new idea and reliable basis for the treatment of different chemotherapeutics-induced chronic pain.</p>
</boxed-text>
<sec id="s1">
<title>Introduction</title>
<p>In spite of their different antitumor mechanisms, any one of the chemotherapeutic drugs oxaliplatin, paclitaxel, or bortezomib causes painful neuropathy (<xref ref-type="bibr" rid="CIT0019">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="CIT0041">Xu et al., 2017</xref>; <xref ref-type="bibr" rid="CIT0024">Meng et al., 2019</xref>). Clinically, the manifestation of painful neuropathy is varied, including tingling, loss of proprioception sense, burning pain, etc. (<xref ref-type="bibr" rid="CIT0011">Haythornthwaite and Benrud-Larson, 2001</xref>; <xref ref-type="bibr" rid="CIT0003">Brandolini et al., 2019</xref>). Similar to clinical manifestations, painful neuropathy is manifested in various forms in rodent models. Among these symptoms, mechanical allodynia is a common phenotype with oxaliplatin, paclitaxel, or bortezomib (<xref ref-type="bibr" rid="CIT0016">Laumet et al., 2015</xref>; <xref ref-type="bibr" rid="CIT0013">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="CIT0036">Stockstill et al., 2018</xref>). Studies showing that transient receptor potential cation channel subfamily V member 1 (TRPV1) play an important role in the burning pain in humans (<xref ref-type="bibr" rid="CIT0035">Simone et al., 1989</xref>; <xref ref-type="bibr" rid="CIT0017">Li et al., 2015</xref>) and thermal hyperalgesia in rats (<xref ref-type="bibr" rid="CIT0010">Hara et al., 2013</xref>) suggested that TRPV1 may be a key ion channel mediating thermal pain. However, it remains unclear whether there is a common ion channel involved in the mechanical allodynia induced by different chemotherapeutic agents.</p>
<p>The excitability of DRG neurons is fundamentally determined by the functional activities of neuronal ion channels in various conditions of chronic pain. For example, the change of sodium channel, calcium channel, or other ion channel in DRG is involved in the chronic pain induced by nerve injury or inflammation (<xref ref-type="bibr" rid="CIT0007">Fischer et al., 2017</xref>; <xref ref-type="bibr" rid="CIT0033">Sakai et al., 2017</xref>; <xref ref-type="bibr" rid="CIT0034">Shan et al., 2019</xref>). Mammalian transient receptor potential (TRP) channel proteins can be classified into 6 subfamilies: TRPC, TRPV, TRPM, TRPA, TRPP, and TRPML (<xref ref-type="bibr" rid="CIT0030">Ramsey et al., 2006</xref>). The TRP cation channel, subfamily C (TRPC) consists of 7 members (TRPC1–7) and serves a wide range of physiological functions ranging from proliferation of cells to mechanical sensory transduction (<xref ref-type="bibr" rid="CIT0025">Nakao et al., 2015</xref>). Among them, TRPC6 upregulation contributed to chronic morphine-induced hyperalgesia (<xref ref-type="bibr" rid="CIT0014">Jin et al., 2017</xref>). Furthermore, TRPC6 is also involved in the mechanical allodynia induced by inflammatory or diabetes (<xref ref-type="bibr" rid="CIT0001">Alessandri-Haber et al., 2009</xref>; <xref ref-type="bibr" rid="CIT0031">Roa-Coria et al., 2019</xref>). Whether TRPC6 is a common molecular to mediate the mechanical allodynia induced by different chemotherapeutics remains unclear. Studies have shown that epigenetic mechanisms such as DNA methylation play an important role in chronic pain through regulating target protein expression (<xref ref-type="bibr" rid="CIT0002">Anis and Mosek, 2018</xref>; <xref ref-type="bibr" rid="CIT0020">Louwies et al., 2019</xref>). However, whether DNA methylation is involved in TRPC6 expression is unknown.</p>
<p>PAX6, as a member of the paired box family, plays a critical role in brain development (<xref ref-type="bibr" rid="CIT0039">Walther and Gruss, 1991</xref>; <xref ref-type="bibr" rid="CIT0040">Wullimann and Rink, 2001</xref>). For example, PAX6 regulates the proliferation of neural stem mediate autism spectrum disorder (<xref ref-type="bibr" rid="CIT0015">Kikkawa et al., 2019</xref>). As a conserved transcription factor with 2 different DNA-binding domains, PAX6 also mediates both embryonic and adult neurogenesis (<xref ref-type="bibr" rid="CIT0028">Osumi et al., 2008</xref>). Furthermore, a recent study showed that adult spinal cord neurogenesis via increasing neuronal excitability contributed to chronic pain (<xref ref-type="bibr" rid="CIT0032">Rusanescu, 2016</xref>). However, to date, no evidence to our knowledge has shown that PAX6 in DRG neurons is involved in chronic pain. In addition, as a transcription factor, whether PAX6 mediates TRPC6 expression remains unclear.</p>
</sec>
<sec id="s2" sec-type="materials">
<title>Materials and Methods</title>
<sec id="s3">
<title>Animals</title>
<p>Male Sprague-Dawley rats weighing 200 to 220 g were obtained from the Institute of Experimental Animals of Sun Yat-sen University and housed in a temperature- and humidity-controlled room (50–60% humidity, 22°C ± 1°C) on a 12-h-light/-dark cycle. Animals were housed in separated cages with ad libitum access to food and water. All experimental protocols were approved by the Animal Care and Use Committee of Sun Yat-sen University and were carried out in accordance with the guidelines of the National Institutes of Health on animal care and ethical guidelines.</p>
<p>Animals were randomly assigned to the experimental groups. Each group included more than 3 animals, and the specific number of animals in each group is indicated in the figure legends. All data were collected and analyzed by 2 independent observers who were blinded to the group assignment of the animals or the treatment group during analysis.</p>
</sec>
<sec id="s4">
<title>Drug Application and Behavioral Test</title>
<p>Oxaliplatin (4 mg/kg, Sigma Aldrich, St. Louis, MO), paclitaxel (8 mg/kg, Bristol-Myers Squibb, New York City, NY), and bortezomib (0.2 mg/kg, Haoran Biological Technology Co., Shanghai, China) were prepared before each treatment and injected i.p. Oxaliplatin or bortezomib was i.p. injected once a day for 5 consecutive days, and paclitaxel was injected once a day on days 1, 4, and 7.</p>
<p>TRPC6 siRNA, PAX6 siRNA, or scramble siRNA (1 nmol, 10 μL, once a day) was injected intrathecally for 10 consecutive days. Intrathecal injection was in accordance with the previous method (<xref ref-type="bibr" rid="CIT0041">Xu et al., 2017</xref>). In brief, a polyethylene-10 catheter was inserted into the L5/L6 intervertebral subarachnoid pace of the rat following the injection of sodium pentobarbital (50 mg/kg, i.p.), and the localization of the catheter tip was placed at the L5 spinal segmental level. After 5 days of recovery, 5 rats with hind limb paralysis or paresis after surgery were excluded from the study.</p>
<p>The 50% paw withdrawal threshold was assessed using von Frey hairs (Ugo Basile, Gemonio, Varese, Italy) according to our and peer’s previous reports (<xref ref-type="bibr" rid="CIT0004">Chaplan et al., 1994</xref>; <xref ref-type="bibr" rid="CIT0041">Xu et al., 2017</xref>). In short, each animal was loosely restrained in a plastic box and allowed to adapt for at least 15 minutes per day for 3 consecutive days before testing. Then, series of von Frey filaments with different bending force were presented to the mid-plantar surface of each hind paw. In the absence of a paw withdrawal response to the initially selected hair, a stronger stimulus was presented; in the event of paw withdrawal, the next weaker stimulus was chosen. Optimal threshold calculation by this method required 6 responses in the immediate vicinity of the 50% threshold.</p>
</sec>
<sec id="s5">
<title>qPCR (Real-time Quantitative PCR Detecting System) and qPCR Array</title>
<p>Under anesthesia using sodium pentobarbital, L4 to L6 DRGs in rats were isolated, and TriZol reagent (Invitrogen, Carlsbad, CA) was used to extract total RNA. The reverse transcription was performed with Prime Script RT Master Mix (Takara Bio Inc., Kusatsu, Shiga, Japan). Real-time quantitative polymerase chain reaction (qPCR) was performed with SYBR Premix Ex TaqII (Takara). The relative expression ratio of mRNA expression was quantified through the 2<sup>-ΔΔCT</sup> method. <xref ref-type="table" rid="T1">Table 1</xref> shows the primer sequences of PCR for the investigated mRNA.</p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>Specific Primer Sequences for qPCR</p>
</caption>
<table frame="vsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1">Gene</th>
<th colspan="1" rowspan="1">Primer</th>
<th colspan="1" rowspan="1">Sequence</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">TRPC6 (Rat)</td>
<td colspan="1" rowspan="1">Forward</td>
<td colspan="1" rowspan="1">5′- GCGGCAGACAGTTCTTCGTGAG -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Reverse</td>
<td colspan="1" rowspan="1">5′- CTTCTAGCATCTTCCGCACCACTG -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1">DNMT1 (Rat)</td>
<td colspan="1" rowspan="1">Forward</td>
<td colspan="1" rowspan="1">5′- GACCAATGAGGCACTGTCCG -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Reverse</td>
<td colspan="1" rowspan="1">5′- GACCGCGACTGCAATACACA -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1">DNMT3a (Rat)</td>
<td colspan="1" rowspan="1">Forward</td>
<td colspan="1" rowspan="1">5′- GGCCCATTCGATCTGGTGA -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Reverse</td>
<td colspan="1" rowspan="1">5′- CTTGGCTATTCTGCCGTGTTC -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1">DNMT3b (Rat)</td>
<td colspan="1" rowspan="1">Forward</td>
<td colspan="1" rowspan="1">5′- GATGATCGACGCCATCAAG -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Reverse</td>
<td colspan="1" rowspan="1">5′- CGAGCTTATCATTCTTTGAAGCTA -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1">PAX6 (Rat)</td>
<td colspan="1" rowspan="1">Forward</td>
<td colspan="1" rowspan="1">5′- CAGAGTTCTTCGCAACCTGGCTAG -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Reverse</td>
<td colspan="1" rowspan="1">5′- GGTCTGTCCGTTCAGCATCCTTAG -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1">β-actin (Rat)</td>
<td colspan="1" rowspan="1">Forward</td>
<td colspan="1" rowspan="1">5′-AGGGAAATCGTGCGTGACAT-3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Reverse</td>
<td colspan="1" rowspan="1">5′-GAACCGCTCATTGCCGATAG-3′</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>For qPCR array, total RNA from DRGs was extracted using RNeasy Mini Kit (Qiagen, 74104; Qiagen, Frankfurt, Germany), and RT<sup>2</sup> Profiler PCR Array (Qiagen, 330401) was used to detect the changes of ion channel.</p>
</sec>
<sec id="s6">
<title>Nucleo-cytoplasmic Separation and Western Blot</title>
<p>The bilateral L4–L6 DRGs of rats were removed under sodium pentobarbital anesthesia (50 mg/kg dose, i.p.). Cytoplasm and nucleus protein of the DRGs were separated according to the manipulation of the NE-PER nuclear and cytoplasmic extraction reagents kit (ThermoFisher Scientific, Waltham, MA) (<xref ref-type="bibr" rid="CIT0026">Nie et al., 2018</xref>). Briefly, the samples were homogenized on ice in a 15-mmol/L Tris buffer containing a cocktail of proteinase inhibitors and phosphatase inhibitors, and the concentration of protein was determined with a BCA protein assay (ThermoFisher Scientific). The protein samples were separated via gel electrophoresis and transferred onto a polyvinylidene fluoride membrane. The membranes were incubated in a primary antibody against TRPC6 (1:200, Alomone Labs, Jerusalem, Israel), PAX6 (1:900, Abcam, Cambridge, UK), DNMT3b (1:500, Abcam), β-actin (1:1000, CST, Boston, MA), and histone H3 (1:1000, Abcam) overnight at 4°C. Horseradish peroxidase-conjugated secondary antibodies were used to incubate the blots. Enhanced chemiluminescence solution (Pierce) was used to detect immunocomplexes. Each band was quantified using a computer-assisted imaging analysis system (NIH ImageJ).</p>
</sec>
<sec id="s7">
<title>Immunohistochemistry</title>
<p>Perfusion was performed through the ascending aorta with 4% paraformaldehyde after application of sodium pentobarbital (50-mg/kg dose, i.p.). The removed DRGs were placed into 4% paraformaldehyde for post fixing overnight. Cryostat sections of 16-μm thickness were obtained, and immunohistochemistry was performed with primary antibodies for TRPC6 (1:100; Alomone Labs), PAX6 (1:200; Abcam), NF200 (1:200; Chemicon), IB4 (1:50; Sigma Aldrich), and GFAP (1:400; CST). After overnight incubation at 4°C, the sections were incubated with secondary antibodies, which conjugated with cy3 or Alex488-fluorescein isothiocyanate for 1 hour at room temperature. A Nikon (Nikon Eclipse Ni-E, Japan) confocal microscopy was used to examine the fluorescence of tissue slices.</p>
</sec>
<sec id="s8">
<title>Reduced Representation Bisulfite Sequencing</title>
<p>Genomic DNA was extracted from DRG of 10 days after chemotherapeutic drug group or vehicle group using the QIAmp DNA Micro Kit (Qiagen, 56 304). Reduced representation bisulfite sequencing (RRBS) sequencing libraries were prepared as describe previously (<xref ref-type="bibr" rid="CIT0008">Gu et al., 2011</xref>). Briefly, a total amount of 5.2 μg genomic DNA spiked with 26 ng lambda DNA was fragmented by sonication to 200 to 300 bp with Covaris S220 followed by end repair and adenylation. Cytosine-methylated barcodes were ligated to sonicated DNA as per manufacturer’s instructions. Furthermore, these DNA fragments were treated twice with bisulfite using an EZ DNA Methylation-Gold Kit (Zymo Research) before the resulting single-strand DNA fragments were PCR amplificated using KAPA HiFi HotStart Uracil + ReadyMix (2X). Qubit 2.0 Fluorometer (Life Technologies, CA) and qPCR were used to quantify library concentration, and the insert size was assayed on an Agilent Bioanalyzer 2100 system. Then the library preparations were sequenced on an Illumina Hiseq 2500/4000 or Novaseq platform, and 125-bp/150-bp paired-end reads were generated. Finally, image analysis and base calling were performed with Illumina CASAVA pipeline, and 125-bp/150-bp paired-end reads were generated.</p>
</sec>
<sec id="s9">
<title>Methylated DNA Immunoprecipitation Assay</title>
<p>Rats were deeply anesthetized with sodium pentobarbital (50-mg/kg dose, i.p.), and then the L4–L6 DRGs were rapidly harvested. The Methylated DNA Immunoprecipitation (MeDIP) methods were used to quantify methylation changes in specific DNA regions of <italic>PAX6</italic> and <italic>IRX5</italic>. In short, genomic DNA extracted from DRG was sheared into random fragments using ultrasound instrument Bioruptor and then incubated with monoclonal 5-methylcytosin antibody overnight at 4°C. Next, magnetic beads conjugated to anti-mouse-IgG are used to bind the anti-5mC antibodies, and the precipitate was rinsed with elution buffer (50 mM Tris-HCl, pH = 8.0; 10 mM EDTA, pH = 8.0; 1% SDS). DNA was purified with phenol-chloroform solution (phenol to chloroform to isoamyl alcohol = 25:24:1) and collected. Finally, qPCR was used to test the expression of PAX6- and IRX5-specific regions. The primer sequences are listed in <xref ref-type="table" rid="T2">Table 2</xref>.</p>
<table-wrap id="T2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption>
<p>Specific Primer Sequences for MeDIP</p>
</caption>
<table frame="vsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1">Gene</th>
<th colspan="1" rowspan="1">Primer</th>
<th colspan="1" rowspan="1">Sequence</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">PAX6 (Rat)</td>
<td colspan="1" rowspan="1">Forward</td>
<td colspan="1" rowspan="1">5′- CCAAATCCTGTAACTCATACC -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Reverse</td>
<td colspan="1" rowspan="1">5′- GCTGGACTGAGATTGACTAGG -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IRX5 (Rat)</td>
<td colspan="1" rowspan="1">Forward</td>
<td colspan="1" rowspan="1">5′- TTCTATCCGGGCTACACGAAC -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Reverse</td>
<td colspan="1" rowspan="1">5′- TCCGCACGATTCAACACCGTC -3′</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s10">
<title>Chromatin Immunoprecipitation Assay</title>
<p>The kit (ThermoFisher Scientific) was used to perform chromatin immunoprecipitation (ChIP) assays. The rats’ L4–L6 DRGs were isolated and placed in 1% formaldehyde for 2 minutes. Sonication was applied to DNA fragments and subsequently digested by micrococcal nuclease. Samples (100 μL) were saved as input after the addition of ChIP dilution buffer. PAX6 antibody or DNMT3b antibody was added to 500 μL for preclearing, and then the samples were incubated overnight. Immunoprecipitation with control mouse IgG (Sigma Aldrich) was performed as a negative control. The DNA was purified from the DNA/antibody complexes through elution and reversion. qPCR was applied on 5 μL of precipitated DNA samples. The primers projected to amplify the specific regions of <italic>TRPC6</italic> were listed in <xref ref-type="table" rid="T3">Table 3</xref>. Finally, the ChIP to input ratio was calculated.</p>
<table-wrap id="T3" orientation="portrait" position="float">
<label>Table 3.</label>
<caption>
<p>Specific Primer Sequences for ChIP</p>
</caption>
<table frame="vsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1">Gene</th>
<th colspan="1" rowspan="1">Primer</th>
<th colspan="1" rowspan="1">Sequence</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">TRPC6 (Rat)</td>
<td colspan="1" rowspan="1">Forward</td>
<td colspan="1" rowspan="1">5′- AACACAGACCGCTCTTCATTTC -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Reverse</td>
<td colspan="1" rowspan="1">5′- AACACTCAGAAAGCAGGGTCC -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1">PAX6 (Rat)</td>
<td colspan="1" rowspan="1">Forward</td>
<td colspan="1" rowspan="1">5′- CCAAATCCTGTAACTCATACC -3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Reverse</td>
<td colspan="1" rowspan="1">5′- GCTGGACTGAGATTGACTAGG -3′</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s11">
<title>siRNA Preparation and Screening</title>
<p>Specific siRNAs were applied to knockdown the expression of TRPC6 and PAX6 in a targeted fashion as previously described (<xref ref-type="bibr" rid="CIT0041">Xu et al., 2017</xref>). Scramble siRNA without any gene homology was used as a negative control. Briefly, siRNAs designed and synthesized by Ribobio (Guangzhou, China) were firstly transfected into the HBZY-1 cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). TRPC6 and PAX6 expression levels were significantly inhibited by detecting with qPCR (data not shown). Our pilot in vivo experiments showed that intrathecal injection of TRPC6 siRNA or PAX6 siRNA also remarkably suppressed the expression of mRNA and protein expression in DRG of rats (data not shown). The nucleotide sequences of TRPC6 and PAX6 siRNA were shown in <xref ref-type="table" rid="T4">Table 4</xref>.</p>
<table-wrap id="T4" orientation="portrait" position="float">
<label>Table 4.</label>
<caption>
<p>Nucleotide Sequences of TRPC6 and PAX6 siRNA</p>
</caption>
<table frame="vsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1">Gene</th>
<th colspan="1" rowspan="1">Primer</th>
<th colspan="1" rowspan="1">Sequence</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">TRPC6</td>
<td colspan="1" rowspan="1">Rat</td>
<td colspan="1" rowspan="1">5‘- GCUCAGAAGAUUUCCAUUU dTdT -3’ (sense)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">5‘- AAAUGGAAAUCUUCUGAGC dTdT -3’ (antisense)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">PAX6</td>
<td colspan="1" rowspan="1">Rat</td>
<td colspan="1" rowspan="1">5‘- CUCCAGAAGUUGUAAGCAA dTdT -3’ (sense)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">5‘- UUGCUUACAACUUCUGGAG dTdT -3’ (antisense)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s12">
<title>Statistical Analysis</title>
<p>All data were expressed as means ± SEM. The results from the behavioral tests, western blot, or qPCR were statistically analyzed with a 1-way or 2-way (repeated-measures) ANOVA followed by Bonferroni post hoc test. The criterion for statistical significance was <italic>P &lt; .</italic>05. Statistical tests were performed with SPSS 25.0 (IBM SPSS).</p>
</sec>
</sec>
<sec id="s13">
<title>Results</title>
<sec id="s14">
<title>Upregulation of TRPC6 in DRG Neurons Contributed to Mechanical Allodynia Induced by Oxaliplatin, Paclitaxel, or Bortezomib Treatment</title>
<p>Consistent with the previous studies (<xref ref-type="bibr" rid="CIT0019">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="CIT0041">Xu et al., 2017</xref>; <xref ref-type="bibr" rid="CIT0042">Zhang et al., 2018</xref>), the mechanical withdrawal threshold of rats was markedly decreased after i.p. administration of oxaliplatin (4 mg/kg once a day for consecutive 5 days), paclitaxel (3 × 8 mg/kg, once a day on days 1, 4, and 7), or bortezomib (0.2 mg/kg once a day for consecutive 5 days). The mechanical allodynia occurred on day 5 and persisted to day 15 (experiment ended) after chemotherapeutics injection (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The common phenotype and similar time course raised a hypothesis maybe there is a common molecule that mediates mechanical allodynia caused by three different chemotherapeutics in DRG. So we examined the mRNA expression of all ion channels in rats’ DRGs by using PCR array. TRPC6 is the only molecular that is significantly upregulated in on 5 and day 15 after all 3 chemotherapeutics treatment (<xref ref-type="fig" rid="F1">Figure 1B</xref>; <xref ref-type="supplementary-material" rid="sup1">supplementary Table 1</xref>). The results of qPCR and western blot further verified that application of oxaliplatin, paclitaxel, or bortezomib evidently enhanced the mRNA (<xref ref-type="fig" rid="F1">Figure 1C</xref>) and protein (<xref ref-type="fig" rid="F1">Figure 1D–F</xref>) levels of TRPC6 in DRG. Double immunofluorescent staining revealed that TRPC6 was primarily expressed in NF200-positive and IB4-positive neurons but not in GFAP-positive satellite glial cells (<xref ref-type="fig" rid="F1">Figure 1G–I</xref>). Importantly, knockdown of TRPC6 by intrathecal injection of TRPC6 siRNA for 10 consecutive days significantly inhibited the mechanical allodynia induced by oxaliplatin, paclitaxel, or bortezomib (<xref ref-type="fig" rid="F1">Figure 1J–L</xref>). Collectively, these results suggested that TRPC6 may be a common molecular mediating chronic pain induced by different chemotherapeutic agents in DRG.</p>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Upregulation of TRPC6 in DRG neurons contributed to mechanical allodynia induced by 3 chemotherapeutics. (A) The hind paw withdraw threshold of rats was obviously reduced following oxaliplatin, paclitaxel, or bortezomib treatment (n = 12 in each group; *<italic>P</italic> &lt; .05, **<italic>P</italic> &lt; .01 vs the vehicle group). (B) The heatmap of PCR array showed the relative mRNA expression of 84 ion channels in DRG following chemotherapeutics treatment (n = 4 in each group). (C–F) The levels of TRPC6 mRNA (C) and protein (D–F) in DRG were significantly upregulated following chemotherapeutics treatment (n = 4 in each group; **<italic>P</italic> &lt; .01 vs the vehicle group). (G–I) The immunofluorescence staining showed the colocalization of TRPC6 (red) with NF200 (a marker for A-type neurons, green) and IB4 (a marker for C-type neurons), but not GFAP (a marker for satellite glial cells, green) in DRG (n = 4 in each group), scale bar = 100 μm. (J–L) Intrathecal injection of TRPC6 siRNA for 10 consecutive days obviously relieved the mechanical allodynia in rats treated with oxaliplatin, paclitaxel, or bortezomib (n = 12 in each group; *<italic>P</italic> &lt; .05, **<italic>P</italic> &lt; .01 vs the vehicle group; #<italic>P</italic> &lt; .05, ##<italic>P</italic> &lt; .01 vs the chemotherapeutics group). BTZ, Bortezomib; Oxal, Oxaliplatin; Pacl, Paclitaxel; Veh, Vehicle.</p>
</caption>
<graphic xlink:href="pyaa014f0001"></graphic>
</fig>
</sec>
<sec id="s15">
<title>Chemotherapeutic Treatment Enhanced the DNA Methylation Level of PAX6 Gene</title>
<p>Studies have shown that DNA methylation-mediated epigenetic mechanisms play an important role in neuropathic pain, and DNA methylation is exclusively found in CpG dinucleotides in mammals. To determine whether DNA methylation is involved in the upregulation of TRPC6, we first observed the methylation change in <italic>TRPC6</italic> loci following the oxaliplatin treatment by using RRBS. The results revealed that the methylation level of <italic>TRPC6</italic> loci did not show a difference on day 15 following the oxaliplatin treatment relative to the vehicle group (<xref ref-type="fig" rid="F2">Figure 2A</xref>). These results suggested that TRPC6 upregulation induced by chemotherapeutic drugs did not come from the change of methylation in <italic>TRPC6</italic> loci per se.</p>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p>The change of PAX6 gene methylation level followed chemotherapeutics treatment. (A) RRBS results showed the change of methylation level in TRPC6 loci before and after oxliplatin treatment. (B) Circos diagram showed DMRs distributed globally across all chromosomes. (C) The Gene Ontology (GO) pathway analysis showed the enrichment degree of biological process with differential DMR mapped genes. (D) Venn diagram showed the overlap of genes between GO analysis and Genomatix database. (E-G) MeDIP assay was performed to detect the change of DNA methylation level in specific regions of PAX6 and IRX5 loci after chemotherapeutics treatment for 15 days in DRG (n = 3 in each group; *<italic>P</italic> &lt; .05, **<italic>P</italic> &lt; .01 vs the correspondence vehicle group). BTZ, Bortezomib; IR, IRX5; Oxal, Oxaliplatin; Pacl, Paclitaxel; PA, PAX6; TFs, Transcription factors; Veh, Vehicle.</p>
</caption>
<graphic xlink:href="pyaa014f0002"></graphic>
</fig>
<p>Although the methylation level in <italic>TRPC6</italic> loci did not change, 1045 differentially methylated regions (DMRs) on chromosomes were observed following the oxaliplatin treatment (<xref ref-type="fig" rid="F2">Figure 2B</xref>). These DMRs were mapped to 811 genes, and Gene Ontology analysis showed that 80 of these genes were closely related with the nervous system development biological process (<xref ref-type="fig" rid="F2">Figure 2C</xref>; <xref ref-type="supplementary-material" rid="sup2">supplementary Table 2</xref>). It is well known that transcription factors play an important role in the target protein expression, so we hypothesize that upregulation of transcription factors mediated by the change of methylation may be involved in the increase of TRPC6 following chemotherapeutic drug treatment. By using Genomatix database analysis, we predicted 50 nervous system-related transcription factors closely related to TRPC6 expression (<xref ref-type="supplementary-material" rid="sup3">supplementary Table 3</xref>). We integrated the analysis of Gene Ontology and Genomatix database and screened 4 transcription factors with potential binding sites to TRPC6 promoter (<xref ref-type="fig" rid="F2">Figure 2D</xref>). Of the 4 transcription factors, PAX6 and iroquois homeobox 5 (IRX5) showed more significant difference of methylation and were chosen for the subsequent study (<xref ref-type="fig" rid="F2">Figure 2D</xref>). Furthermore, we explored the methylation level of DMR in PAX6 or IRX5 by using the anti-5-mc–mediated MeDIP assay. The results showed that the methylation level of <italic>PAX6</italic> DNA, but not <italic>IRX5</italic> DNA, containing the DMR (chr3: 330−440 for <italic>PAX6</italic> and chr19: 4365−4481 for <italic>IRX5</italic>) decreased significantly following oxaliplatin, paclitaxel, or bortezomib treatment (<xref ref-type="fig" rid="F2">Figure 2E–G</xref>). These results implied that the hypomethylation of transcription factor <italic>PAX6</italic> gene may be a common signal event induced by different chemotherapeutic agents.</p>
</sec>
<sec id="s16">
<title>Chemotherapeutics Treatment Decreased the Recruitment of DNMT3b on PAX6 Gene</title>
<p>It is well known that DNA methyltransferases (DNMT), including DNMT1, DNMT3a, and DNMT3b, via translocating into the nucleus contributed to the DNA methylation in mammals (<xref ref-type="bibr" rid="CIT0038">Ventham et al., 2013</xref>; <xref ref-type="bibr" rid="CIT0006">Day et al., 2015</xref>; <xref ref-type="bibr" rid="CIT0027">Norollahi et al., 2019</xref>). To understand the mechanism underlying the hypomethylation of <italic>PAX6</italic> gene, we first explored the expression of all DNMT mRNA following chemotherapeutics treatment. The results showed that the mRNA level of DNMT3b, but not DNMT1 or DNMT3a, was markedly decreased on day 5 and day 15 following chemotherapeutics injection (<xref ref-type="fig" rid="F3">Figure 3A–C</xref>). Furthermore, the level of DNMT3b protein in nuclei was significantly decreased following the chemotherapeutics treatment compared with the vehicle group (<xref ref-type="fig" rid="F3">Figure 3D–F</xref>). Importantly, ChIP-PCR assay showed that the recruitment of DNMT3b at DMR of <italic>PAX6</italic> gene (+330 − +440) was significantly downregulated after all 3 chemotherapeutics treatments, respectively (<xref ref-type="fig" rid="F3">Figure 3G–I</xref>). These results suggested that chemotherapeutics via decreased levels of nucleus DNMT3b downregulated the recruitment of DNMT3b at the PAX6 gene.</p>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<p>The change of DNMTs in DRG following 3 chemotherapeutics treatment. (A-C) The mRNA levels of DNMT1, DNMT3a, and DNMT3b were explored in DRG on days 5 and 15 following chemotherapeutics treatment (n = 6 in each group; *<italic>P</italic> &lt; .05, **<italic>P</italic> &lt; .01 vs the vehicle group). (D–F) Nuclei DNMT3b protein level was significantly decreased following chemotherapeutics treatment on days 5 and 15 (n = 4 in each group; *<italic>P</italic> &lt; .05, **<italic>P</italic> &lt; .01 vs the vehicle group). (G–I) ChIP assays were performed with DNMT3b antibody on day 15 following chemotherapeutics treatment (n = 3 in each group; *<italic>P</italic> &lt; .05, **<italic>P</italic> &lt; .01 vs the corresponding vehicle group). BTZ, Bortezomib; Oxal, Oxaliplatin; Pacl, Paclitaxel; Veh, Vehicle.</p>
</caption>
<graphic xlink:href="pyaa014f0003"></graphic>
</fig>
</sec>
<sec id="s17">
<title>Enhanced Expression of PAX6 in DRG Neurons Involved in Mechanical Allodynia Induced by Chemotherapeutics</title>
<p>Previous study has established that DNA hypomethylation via promoting target gene transcription mediated the target protein upregulation (<xref ref-type="bibr" rid="CIT0029">Ozaki et al., 2017</xref>). Here, qPCR and western-blot analysis revealed that chemotherapeutics treatment significantly upregulated the expression of PAX6 mRNA (<xref ref-type="fig" rid="F4">Figure 4A</xref>) and protein (<xref ref-type="fig" rid="F4">Figure 4B–D</xref>) in the DRG on day 5 and day 15. The double immunostaining showed that PAX6 was primarily expressed in NF200-positive and IB4-positive cells, but not GFAP-positive cells (<xref ref-type="fig" rid="F4">Figure 4E</xref>). Importantly, intrathecal injection of PAX6 siRNA for 10 continuous days markedly attenuated the mechanical allodynia induced by oxaliplatin (<xref ref-type="fig" rid="F4">Figure 4F</xref>), paclitaxel (<xref ref-type="fig" rid="F4">Figure 4G</xref>), or bortezomib (<xref ref-type="fig" rid="F4">Figure 4H</xref>) treatment. These results demonstrated that the increased expression of PAX6 in DRG neurons participated in mechanical allodynia induced by chemotherapeutics.</p>
<fig id="F4" orientation="portrait" position="float">
<label>Figure 4.</label>
<caption>
<p>Increased expression of PAX6 in DRG neurons was involved in mechanical allodynia induced by 3 chemotherapeutics. (A) The expression of PAX6 mRNA was significantly increased following oxaliplatin, paclitaxel, or bortezomib treatment (n = 6 in each group; **<italic>P</italic> &lt; .01 vs the vehicle group). (B–D) Representative blots and histograms showed the total expression of PAX6 protein after chemotherapeutics treatment (n = 4 in each group; *<italic>P</italic> &lt; .05, **<italic>P</italic> &lt; .01 vs the vehicle group). (E) The immunofluorescence staining showed the colocalization of PAX6 (red) with NF200 (a marker for A-type neurons, green) and IB4 (a marker for C-type neurons), but not GFAP (a marker for satellite glial cells, green) in DRG (n = 4 in each group), scale bar = 100 μm. (F–H) Intrathecal injection of PAX6 siRNA obviously attenuated the mechanical allodynia induced by oxaliplatin, paclitaxel, or bortezomib (n = 12 in each group; *<italic>P</italic> &lt; .05, **<italic>P</italic> &lt; .01 vs the vehicle group, #<italic>P</italic> &lt; .05, ##<italic>P</italic> &lt; .01 vs the corresponding chemotherapeutics group). BTZ, Bortezomib; Oxal, Oxaliplatin; Pacl, Paclitaxel; Veh, Vehicle.</p>
</caption>
<graphic xlink:href="pyaa014f0004"></graphic>
</fig>
</sec>
<sec id="s18">
<title>PAX6 Contributed to Upregulation of TRPC6 Following Chemotherapeutics Treatment</title>
<p>Next, we further validated whether the upregulated transcription factor PAX6 mediated the TRPC6 expression following chemotherapeutics treatment. Double immunostaining showed that the expression of PAX6 was colocalized with TRPC6-positive cells in DRG (<xref ref-type="fig" rid="F5">Figure 5A</xref>). Intrathecal injection of PAX6 siRNA for 10 consecutive days obviously prevented the upregulation of TRPC6 protein in DRG on day 15 following chemotherapeutics treatment (<xref ref-type="fig" rid="F5">Figure 5B–D</xref>). Next, TFSEARCH and JASPAR database analysis showed that the position of <italic>TRPC6</italic> (−636/−625) is a potent binding site for PAX6. The DNA, precipitated by the PAX6 antibody, was subjected to PCR to amplify a 128-bp fragment (−727/−600) of the TRPC6 promoter, which contained the PAX6-binding site with the designed primers. ChIP-qPCR analysis revealed that the recruitment of PAX6 to the <italic>TRPC6</italic> promoter was markedly increased on day 15 after application of chemotherapeutics relative to the vehicle group. Importantly, the enhanced binding between PAX6 and <italic>TRPC6</italic> promoter was decreased in rats with application of PAX6 siRNA following chemotherapeutic treatment (<xref ref-type="fig" rid="F5">Figure 5E–G</xref>).</p>
<fig id="F5" orientation="portrait" position="float">
<label>Figure 5.</label>
<caption>
<p>Increased PAX6 mediated TRPC6 upregulation in DRG neurons following chemotherapeutics treatment. (A) The double immunofluorescence staining indicated colocalization of PAX6 with TRPC6 in DRG neurons of rats (n = 4 in each group), scale bar = 100 μm. (B–D) Intrathecal injection of PAX6 siRNA significantly prevented the chemotherapeutics-induced TRPC6 upregulation (n = 4 in each group, **<italic>P</italic> &lt; .01 vs the vehicle group, ##<italic>P</italic> &lt; .01 vs the corresponding chemotherapeutics group). (E–G) Following PAX6 siRNA application (i.t.), ChIP assay was performed with PAX6 antibody on day 15 after chemotherapeutics treatment in rats (n = 3 in each group, **<italic>P</italic> &lt; .01 vs the vehicle group, ##<italic>P</italic> &lt; .01 vs the corresponding chemotherapeutic group). BTZ, Bortezomib; Oxal, Oxaliplatin; Pacl, Paclitaxel; Veh, Vehicle.</p>
</caption>
<graphic xlink:href="pyaa014f0005"></graphic>
</fig>
</sec>
</sec>
<sec id="s19">
<title>Discussion</title>
<p>It has been suggested that ion channels in DRG neurons are involved in the neuropathic pain following nerve injury or inflammatory (<xref ref-type="bibr" rid="CIT0018">Lin et al., 2016</xref>; <xref ref-type="bibr" rid="CIT0021">Mao et al., 2017</xref>). TRP channels have a physiological role in the mechanisms controlling several physiological responses like temperature and mechanical sensations (<xref ref-type="bibr" rid="CIT0022">Marwaha et al., 2016</xref>). For example, heat activates TRPVs (<xref ref-type="bibr" rid="CIT0009">Guler et al., 2002</xref>; <xref ref-type="bibr" rid="CIT0012">Hong and Wiley, 2005</xref>), while cold temperatures ranging from affable to painful activate TRPA1 and TRPM8 (<xref ref-type="bibr" rid="CIT0023">McKemy et al., 2002</xref>; <xref ref-type="bibr" rid="CIT0037">Story et al., 2003</xref>). Among TRPC channels, a recent study showed that the spinal TRPC6 channel contributes to morphine-induced hyperalgesia (<xref ref-type="bibr" rid="CIT0014">Jin et al., 2017</xref>). In the present study, qPCR array analysis first showed that application of 3 chemotherapeutic drugs with different antitumor mechanisms only upregulated the expression of TRPC6 in DRG neurons. Inhibition of TRPC6 by intrathecal injection of TRPC6 siRNA attenuated the mechanical allodynia induced by 3 chemotherapeutics. These results first indicated that TRPC6 upregulation in DRG neurons participated in different chemotherapeutic-induced mechanical allodynia. This result is similar with that TRPC6 is involved in the mechanical hyperalgesia induced by inflammatory or nerve injury (<xref ref-type="bibr" rid="CIT0001">Alessandri-Haber et al., 2009</xref>; <xref ref-type="bibr" rid="CIT0031">Roa-Coria et al., 2019</xref>). While the possibility existed that the analgesia induced by intrathecal dosing scheme in the present study might be partially supplemented with its potential effect on spinal cord, our results at least showed that the TRPC6 in DRG might be a common therapeutic target for mechanical allodynia induced by chemotherapeutics.</p>
<p>In the current study, we further found that the expression of TRPC6 increased following chemotherapeutic treatment. Given that DNA methylation plays a critical role in the enhancement of target gene transcription, we examined the change of the DAN methylation level of TRPC6. Unexpectedly, the methylation level of TRPC6 loci was not affected following oxaliplatin treatment. Studies showed that upregulation and translocation of the transcriptional factor into the nucleus is a canonical way to regulate target gene expression. Furthermore, we found that 80 genes with methylation changes are mainly enriched on the nervous system biological process. Integrated with bioinformatics analysis, PAX6 may be a key transcriptional factor for TRPC6 upregulation, as PAX6 is fit for these criteria that hypomethylation of PAX6 loci and can bind to TRPC6 promotor as a transcription factor. To prove this hypothesis, we first observed the role of PAX6 in the mechanical allodynia. The results showed that chemotherapeutic treatment increased PAX6 expression and local suppression of TRPC6 by using siRNA ameliorated mechanical allodynia. Although evidence showed that PAX6 plays a key role in neurogenesis, which contributed to hyperalgesia in the spinal cord (<xref ref-type="bibr" rid="CIT0032">Rusanescu, 2016</xref>), the present study is the first time to testify that PAX6 DRG neurons participated in the chronic pain induced by chemotherapeutics. As a transcriptional factor, PAX6 regulated target gene expression by binding to the promoter (<xref ref-type="bibr" rid="CIT0005">Cvekl et al., 2004</xref>). Here, we also found that chemotherapeutics increased the binding between PAX6 and <italic>TPRC6</italic> promoter and application of PAX6 siRNA attenuated the interaction. Moreover, the increased PAX6 mRNA resulted from the hypomethylation of PAX6 loci mediated by DNMT3b, because the expression of DNMT3b and its binding with PAX6 gene were significantly decreased after application of chemotherapeutics. Up to now, the results first showed that DNMT3b is involved in the hypomethylation of PAX6, suggesting that inhibition of DNMT3b-mediated hypomethylation of PAX6 in DRG might be a novel therapy target for chronic pain.</p>
<p>In conclusion, our study revealed that the activation of PAX6/TRPC6 in DRG neurons may be a common signal pathway for mechanical allodynia following 3 chemotherapeutics application. Furthermore, hypomethylation-mediated epigenetic mechanisms in <italic>PAX6</italic> gene might have contributed to the upregulation of the PAX6/TRPC6 pathway. So focusing on PAX6/TRPC6 signaling may provide new ideas and a reliable basis for the treatment of different chemotherapeutics-induced chronic pain.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="sup1">
<label>pyaa014_suppl_Supplementary_Table_1</label>
<media xlink:href="pyaa014_suppl_supplementary_table_1.doc">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="sup2">
<label>pyaa014_suppl_Supplementary_Table_2</label>
<media xlink:href="pyaa014_suppl_supplementary_table_2.doc">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="sup3">
<label>pyaa014_suppl_Supplementary_Table_3</label>
<media xlink:href="pyaa014_suppl_supplementary_table_3.doc">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="a1">
<title>Acknowledgments</title>
<p>The authors are entirely responsible for the scientific content of the article.</p>
</ack>
<sec id="s0104">
<title></title>
<p>This study was supported by the National Natural Science Foundation of China (no. 81801103), the China Postdoctoral Science Foundation (nos. 2018M631019 and 2019T120767), the Fundamental Research Funds for the Central Universities (No. 18ykpy41), the Guangzhou Innovation Platform construction Project (No. 2060404), the Natural Science Foundation of Guangdong Province (2019A1515010871), and the 111 Project (No. B13037).</p>
<p>Statement of InterestNone.</p>
</sec>
<ref-list id="r1">
<title>References</title>
<ref id="CIT0001">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Alessandri-Haber</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Dina</surname><given-names>OA</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Levine</surname><given-names>JD</given-names></name></person-group> (<year>2009</year>) <article-title>TRPC1 and TRPC6 channels cooperate with TRPV4 to mediate mechanical hyperalgesia and nociceptor sensitization</article-title>. <source/>J Neurosci<volume>29</volume>:<fpage>6217</fpage>–<lpage>6228</lpage>.<pub-id pub-id-type="pmid">19439599</pub-id></mixed-citation>
</ref>
<ref id="CIT0002">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Anis</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mosek</surname><given-names>A</given-names></name></person-group> (<year>2018</year>) <article-title>[Epigenetic mechanisms in models of chronic pain - a target for novel therapy?]</article-title>. <source/>Harefuah<volume>157</volume>:<fpage>370</fpage>–<lpage>373</lpage>.<pub-id pub-id-type="pmid">29964377</pub-id></mixed-citation>
</ref>
<ref id="CIT0003">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brandolini</surname><given-names>L</given-names></name>, <name name-style="western"><surname>d’Angelo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Antonosante</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Allegretti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cimini</surname><given-names>A</given-names></name></person-group> (<year>2019</year>) <article-title>Chemokine signaling in chemotherapy-induced neuropathic pain</article-title>. <source/>Int J Mol Sci<volume>20</volume>:<fpage>2904</fpage>.</mixed-citation>
</ref>
<ref id="CIT0004">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chaplan</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Bach</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>Pogrel</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Yaksh</surname><given-names>TL</given-names></name></person-group> (<year>1994</year>) <article-title>Quantitative assessment of tactile allodynia in the rat paw</article-title>. <source/>J Neurosci Methods<volume>53</volume>:<fpage>55</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">7990513</pub-id></mixed-citation>
</ref>
<ref id="CIT0005">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cvekl</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chauhan</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Cveklova</surname><given-names>K</given-names></name></person-group> (<year>2004</year>) <article-title>Regulation of gene expression by Pax6 in ocular cells: a case of tissue-preferred expression of crystallins in lens</article-title>. <source/>Int J Dev Biol<volume>48</volume>:<fpage>829</fpage>–<lpage>844</lpage>.<pub-id pub-id-type="pmid">15558475</pub-id></mixed-citation>
</ref>
<ref id="CIT0006">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Day</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Sweatt</surname><given-names>JD</given-names></name></person-group> (<year>2015</year>) <article-title>DNA methylation and its implications and accessibility for neuropsychiatric therapeutics</article-title>. <source/>Annu Rev Pharmacol Toxicol<volume>55</volume>:<fpage>591</fpage>–<lpage>611</lpage>.<pub-id pub-id-type="pmid">25340930</pub-id></mixed-citation>
</ref>
<ref id="CIT0007">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kuzin</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Bottaro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>O’Leary</surname><given-names>ME</given-names></name></person-group> (<year>2017</year>) <article-title>Chronic exposure to tumor necrosis factor in vivo induces hyperalgesia, upregulates sodium channel gene expression and alters the cellular electrophysiology of dorsal root ganglion neurons</article-title>. <source/>Neurosci Lett<volume>653</volume>:<fpage>195</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">28558976</pub-id></mixed-citation>
</ref>
<ref id="CIT0008">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>ZD</given-names></name>, <name name-style="western"><surname>Bock</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Boyle</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gnirke</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Meissner</surname><given-names>A</given-names></name></person-group> (<year>2011</year>) <article-title>Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling</article-title>. <source/>Nat Protoc<volume>6</volume>:<fpage>468</fpage>–<lpage>481</lpage>.<pub-id pub-id-type="pmid">21412275</pub-id></mixed-citation>
</ref>
<ref id="CIT0009">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Güler</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Iida</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Tominaga</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Caterina</surname><given-names>M</given-names></name></person-group> (<year>2002</year>) <article-title>Heat-evoked activation of the ion channel, TRPV4</article-title>. <source/>J Neurosci<volume>22</volume>:<fpage>6408</fpage>–<lpage>6414</lpage>.<pub-id pub-id-type="pmid">12151520</pub-id></mixed-citation>
</ref>
<ref id="CIT0010">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hara</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chiba</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Abe</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Makabe</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ikeno</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kawakami</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Utsunomiya</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Hama</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Taguchi</surname><given-names>K</given-names></name></person-group> (<year>2013</year>) <article-title>Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion</article-title>. <source/>Pain<volume>154</volume>:<fpage>882</fpage>–<lpage>889</lpage>.<pub-id pub-id-type="pmid">23602343</pub-id></mixed-citation>
</ref>
<ref id="CIT0011">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Haythornthwaite</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Benrud-Larson</surname><given-names>LM</given-names></name></person-group> (<year>2001</year>) <article-title>Psychological assessment and treatment of patients with neuropathic pain</article-title>. <source/>Curr Pain Headache Rep<volume>5</volume>:<fpage>124</fpage>–<lpage>129</lpage>.<pub-id pub-id-type="pmid">11252146</pub-id></mixed-citation>
</ref>
<ref id="CIT0012">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wiley</surname><given-names>JW</given-names></name></person-group> (<year>2005</year>) <article-title>Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1</article-title>. <source/>J Biol Chem<volume>280</volume>:<fpage>618</fpage>–<lpage>627</lpage>.<pub-id pub-id-type="pmid">15513920</pub-id></mixed-citation>
</ref>
<ref id="CIT0013">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>ZZ</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ou-Yang</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>XG</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xin</surname><given-names>WJ</given-names></name></person-group> (<year>2016</year>) <article-title>Cerebrospinal fluid oxaliplatin contributes to the acute pain induced by systemic administration of oxaliplatin</article-title>. <source/>Anesthesiology<volume>124</volume>:<fpage>1109</fpage>–<lpage>1121</lpage>.<pub-id pub-id-type="pmid">26978408</pub-id></mixed-citation>
</ref>
<ref id="CIT0014">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>YT</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>GQ</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>XN</given-names></name></person-group> (<year>2017</year>) <article-title>Spinal TRPC6 channels contributes to morphine-induced antinociceptive tolerance and hyperalgesia in rats</article-title>. <source/>Neurosci Lett<volume>639</volume>:<fpage>138</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">28034782</pub-id></mixed-citation>
</ref>
<ref id="CIT0015">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kikkawa</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Casingal</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Chun</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Shinohara</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hiraoka</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Osumi</surname><given-names>N</given-names></name></person-group> (<year>2019</year>) <article-title>The role of Pax6 in brain development and its impact on pathogenesis of autism spectrum disorder</article-title>. <source/>Brain Res<volume>1705</volume>:<fpage>95</fpage>–<lpage>103</lpage>.<pub-id pub-id-type="pmid">29499177</pub-id></mixed-citation>
</ref>
<ref id="CIT0016">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Laumet</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Garriga</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jelinek</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cesaroni</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Issa</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>HL</given-names></name></person-group> (<year>2015</year>) <article-title>G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition</article-title>. <source/>Nat Neurosci<volume>18</volume>:<fpage>1746</fpage>–<lpage>1755</lpage>.<pub-id pub-id-type="pmid">26551542</pub-id></mixed-citation>
</ref>
<ref id="CIT0017">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Adamek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tatsui</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Rhines</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Mrozkova</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Kosturakis</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Cassidy</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Cata</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Sapire</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kennamer-Chapman</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Jawad</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Ghetti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Palecek</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dougherty</surname><given-names>PM</given-names></name></person-group> (<year>2015</year>) <article-title>The cancer chemotherapeutic paclitaxel increases human and rodent sensory neuron responses to TRPV1 by activation of TLR4</article-title>. <source/>J Neurosci<volume>35</volume>:<fpage>13487</fpage>–<lpage>13500</lpage>.<pub-id pub-id-type="pmid">26424893</pub-id></mixed-citation>
</ref>
<ref id="CIT0018">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>YG</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>XJ</given-names></name></person-group> (<year>2016</year>) <article-title>Colocalization of insulin-like growth factor-1 receptor and T type Cav3.2 channel in dorsal root ganglia in chronic inflammatory pain mouse model</article-title>. <source/>Neuroreport<volume>27</volume>:<fpage>737</fpage>–<lpage>743</lpage>.<pub-id pub-id-type="pmid">27213932</pub-id></mixed-citation>
</ref>
<ref id="CIT0019">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Luan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>OuYang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xin</surname><given-names>W</given-names></name></person-group> (<year>2016</year>) <article-title>Upregulation of CCL2 via ATF3/c-Jun interaction mediated the bortezomib-induced peripheral neuropathy</article-title>. <source/>Brain Behav Immun<volume>53</volume>:<fpage>96</fpage>–<lpage>104</lpage>.<pub-id pub-id-type="pmid">26554515</pub-id></mixed-citation>
</ref>
<ref id="CIT0020">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Louwies</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ligon</surname><given-names>CO</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Greenwood-Van Meerveld</surname><given-names>B</given-names></name></person-group> (<year>2019</year>) <article-title>Targeting epigenetic mechanisms for chronic visceral pain: a valid approach for the development of novel therapeutics</article-title>. <source/>Neurogastroenterol Motil<volume>31</volume>:<fpage>e13500</fpage>.<pub-id pub-id-type="pmid">30393913</pub-id></mixed-citation>
</ref>
<ref id="CIT0021">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ming</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bekker</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>YX</given-names></name></person-group> (<year>2017</year>) <article-title>Role of dorsal root ganglion K2p1.1 in peripheral nerve injury-induced neuropathic pain</article-title>. <source/>Mol Pain<volume>13</volume>:<fpage>1744806917701135</fpage>.<pub-id pub-id-type="pmid">28326939</pub-id></mixed-citation>
</ref>
<ref id="CIT0022">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Marwaha</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bansal</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Saroj</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bhandari</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kuhad</surname><given-names>A</given-names></name></person-group> (<year>2016</year>) <article-title>TRP channels: potential drug target for neuropathic pain</article-title>. <source/>Inflammopharmacology<volume>24</volume>:<fpage>305</fpage>–<lpage>317</lpage>.<pub-id pub-id-type="pmid">27757589</pub-id></mixed-citation>
</ref>
<ref id="CIT0023">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>McKemy</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Neuhausser</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Julius</surname><given-names>D</given-names></name></person-group> (<year>2002</year>) <article-title>Identification of a cold receptor reveals a general role for TRP channels in thermosensation</article-title>. <source/>Nature<volume>416</volume>:<fpage>52</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="pmid">11882888</pub-id></mixed-citation>
</ref>
<ref id="CIT0024">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Meng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name></person-group> (<year>2019</year>) <article-title>Duloxetine, a balanced serotonin-norepinephrine reuptake inhibitor, improves painful chemotherapy-induced peripheral neuropathy by inhibiting activation of p38 MAPK and NF-κB</article-title>. <source/>Front Pharmacol<volume>10</volume>:<fpage>365</fpage>.<pub-id pub-id-type="pmid">31024320</pub-id></mixed-citation>
</ref>
<ref id="CIT0025">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Nakao</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Minato</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Uemoto</surname><given-names>S</given-names></name></person-group> (<year>2015</year>) <source/>Innovative medicine: basic research and development. <publisher-loc>Tokyo</publisher-loc>: <publisher-name>Springer</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0026">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nie</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Xin</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Ouyang</surname><given-names>H</given-names></name></person-group> (<year>2018</year>) <article-title>AKAP150 involved in paclitaxel-induced neuropathic pain via inhibiting CN/NFAT2 pathway and downregulating IL-4</article-title>. <source/>Brain Behav Immun<volume>68</volume>:<fpage>158</fpage>–<lpage>168</lpage>.<pub-id pub-id-type="pmid">29056557</pub-id></mixed-citation>
</ref>
<ref id="CIT0027">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Norollahi</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Mansour-Ghanaei</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Joukar</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ghadarjani</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mojtahedi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gharaei Nejad</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hemmati</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gharibpoor</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Khaksar</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Samadani</surname><given-names>AA</given-names></name></person-group> (<year>2019</year>) <article-title>Therapeutic approach of cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy</article-title>. <source/>Biomed Pharmacother<volume>115</volume>:<fpage>108958</fpage>.<pub-id pub-id-type="pmid">31075731</pub-id></mixed-citation>
</ref>
<ref id="CIT0028">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Osumi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Shinohara</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Numayama-Tsuruta</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Maekawa</surname><given-names>M</given-names></name></person-group> (<year>2008</year>) <article-title>Concise review: Pax6 transcription factor contributes to both embryonic and adult neurogenesis as a multifunctional regulator</article-title>. <source/>Stem Cells<volume>26</volume>:<fpage>1663</fpage>–<lpage>1672</lpage>.<pub-id pub-id-type="pmid">18467663</pub-id></mixed-citation>
</ref>
<ref id="CIT0029">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ozaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yoshino</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yamazaki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sao</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mori</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ochi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mori</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Iga</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Ueno</surname><given-names>SI</given-names></name></person-group> (<year>2017</year>) <article-title>DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer’s disease</article-title>. <source/>J Psychiatr Res<volume>92</volume>:<fpage>74</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">28412600</pub-id></mixed-citation>
</ref>
<ref id="CIT0030">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ramsey</surname><given-names>IS</given-names></name>, <name name-style="western"><surname>Delling</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Clapham</surname><given-names>DE</given-names></name></person-group> (<year>2006</year>) <article-title>An introduction to TRP channels</article-title>. <source/>Annu Rev Physiol<volume>68</volume>:<fpage>619</fpage>–<lpage>647</lpage>.<pub-id pub-id-type="pmid">16460286</pub-id></mixed-citation>
</ref>
<ref id="CIT0031">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Roa-Coria</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Pineda-Farias</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Barragán-Iglesias</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Quiñonez-Bastidas</surname><given-names>GN</given-names></name>, <name name-style="western"><surname>Zúñiga-Romero</surname><given-names>Á</given-names></name>, <name name-style="western"><surname>Huerta-Cruz</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Reyes-García</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Flores-Murrieta</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Granados-Soto</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Rocha-González</surname><given-names>HI</given-names></name></person-group> (<year>2019</year>) <article-title>Possible involvement of peripheral TRP channels in the hydrogen sulfide-induced hyperalgesia in diabetic rats</article-title>. <source/>BMC Neurosci<volume>20</volume>:<fpage>1</fpage>.<pub-id pub-id-type="pmid">30602386</pub-id></mixed-citation>
</ref>
<ref id="CIT0032">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rusanescu</surname><given-names>G</given-names></name></person-group> (<year>2016</year>) <article-title>Adult spinal cord neurogenesis: a regulator of nociception</article-title>. <source/>Neurogenesis (Austin)<volume>3</volume>:<fpage>e1256853</fpage>.<pub-id pub-id-type="pmid">28405586</pub-id></mixed-citation>
</ref>
<ref id="CIT0033">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sakai</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Saitow</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Maruyama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Miyake</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Miyake</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Shimada</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Okada</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>H</given-names></name></person-group> (<year>2017</year>) <article-title>MicroRNA cluster miR-17-92 regulates multiple functionally related voltage-gated potassium channels in chronic neuropathic pain</article-title>. <source/>Nat Commun<volume>8</volume>:<fpage>16079</fpage>.<pub-id pub-id-type="pmid">28677679</pub-id></mixed-citation>
</ref>
<ref id="CIT0034">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shan</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Vallecillo</surname><given-names>TGM</given-names></name>, <name name-style="western"><surname>Serafini</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Pham</surname><given-names>NYN</given-names></name>, <name name-style="western"><surname>Bellampalli</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Moutal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Patek</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Streicher</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Gunatilaka</surname><given-names>AAL</given-names></name>, <name name-style="western"><surname>Khanna</surname><given-names>R</given-names></name></person-group> (<year>2019</year>) <article-title>Reversal of peripheral neuropathic pain by the small-molecule natural product physalin F via Block of CaV2.3 (R-Type) and CaV2.2 (N-Type) voltage-gated calcium channels</article-title>. <source/>ACS Chem Neurosci<volume>10</volume>:<fpage>2939</fpage>–<lpage>2955</lpage>.<pub-id pub-id-type="pmid">30946560</pub-id></mixed-citation>
</ref>
<ref id="CIT0035">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Simone</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Baumann</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>LaMotte</surname><given-names>RH</given-names></name></person-group> (<year>1989</year>) <article-title>Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin</article-title>. <source/>Pain<volume>38</volume>:<fpage>99</fpage>–<lpage>107</lpage>.<pub-id pub-id-type="pmid">2780068</pub-id></mixed-citation>
</ref>
<ref id="CIT0036">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Stockstill</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Doyle</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Janes</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Little</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Braden</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lauro</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Giancotti</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Harada</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Yadav</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Lionberger</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Neumann</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Weng</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Spiegel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Salvemini</surname><given-names>D</given-names></name></person-group> (<year>2018</year>) <article-title>Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain</article-title>. <source/>J Exp Med<volume>215</volume>:<fpage>1301</fpage>–<lpage>1313</lpage>.<pub-id pub-id-type="pmid">29703731</pub-id></mixed-citation>
</ref>
<ref id="CIT0037">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Story</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Peier</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Reeve</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Eid</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Mosbacher</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hricik</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Earley</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Hergarden</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Andersson</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>McIntyre</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Jegla</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bevan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Patapoutian</surname><given-names>A</given-names></name></person-group> (<year>2003</year>) <article-title>ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures</article-title>. <source/>Cell<volume>112</volume>:<fpage>819</fpage>–<lpage>829</lpage>.<pub-id pub-id-type="pmid">12654248</pub-id></mixed-citation>
</ref>
<ref id="CIT0038">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ventham</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Nimmo</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Satsangi</surname><given-names>J</given-names></name></person-group> (<year>2013</year>) <article-title>Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics</article-title>. <source/>Gastroenterology<volume>145</volume>:<fpage>293</fpage>–<lpage>308</lpage>.<pub-id pub-id-type="pmid">23751777</pub-id></mixed-citation>
</ref>
<ref id="CIT0039">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Walther</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gruss</surname><given-names>P</given-names></name></person-group> (<year>1991</year>) <article-title>Pax-6, a murine paired box gene, is expressed in the developing CNS</article-title>. <source/>Development<volume>113</volume>:<fpage>1435</fpage>–<lpage>1449</lpage>.<pub-id pub-id-type="pmid">1687460</pub-id></mixed-citation>
</ref>
<ref id="CIT0040">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wullimann</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Rink</surname><given-names>E</given-names></name></person-group> (<year>2001</year>) <article-title>Detailed immunohistology of Pax6 protein and tyrosine hydroxylase in the early zebrafish brain suggests role of Pax6 gene in development of dopaminergic diencephalic neurons</article-title>. <source/>Brain Res Dev Brain Res<volume>131</volume>:<fpage>173</fpage>–<lpage>191</lpage>.<pub-id pub-id-type="pmid">11718849</pub-id></mixed-citation>
</ref>
<ref id="CIT0041">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Ou-Yang</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>ZY</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>ZZ</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Nie</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Xin</surname><given-names>WJ</given-names></name></person-group> (<year>2017</year>) <article-title>Epigenetic upregulation of CXCL12 expression mediates antitubulin chemotherapeutics-induced neuropathic pain</article-title>. <source/>Pain<volume>158</volume>:<fpage>637</fpage>–<lpage>648</lpage>.<pub-id pub-id-type="pmid">28072604</pub-id></mixed-citation>
</ref>
<ref id="CIT0042">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Xin</surname><given-names>WJ</given-names></name></person-group> (<year>2018</year>) <article-title>Palmitoylation of delta-catenin promotes kinesin-mediated membrane trafficking of Nav1.6 in sensory neurons to promote neuropathic pain</article-title>. <source/>Sci Signal<volume>11</volume>:<fpage>eaar4394</fpage>.<pub-id pub-id-type="pmid">29588412</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>